Revive Therapeutics Ltd.

C$0.02As of Sun 8 Nov 2026, 12:00 UTC
CSE:RVVHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (18.48%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (1.82)
PE TTM —
TSR TTM 33.33%
Mkt cap C$8.892M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.024
19.79%
(25.83%)
Hold 8|4|12|4|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
22.42%
25.69%
13.04%
4.38%
Revenue$M
0.625
0.609
0.602
0.628
8.23%
2.99%
(0.96%)
5.40%
Peers (US$6.294M)
Cap (US$)
PE
6.093M
—
Capital
TTM
5Y
10Y
Leveragex
0.831
(1.031)
(0.817)
EBIT/Intx
2.192
1.012
1.056
Own earn%
35.64
57.97
55.91
Sh yield%
28.01
44.76
44.72
Owners
Insiders/Inst%
11.60
64.06
Short interest%
1.19
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
23–28
$1 testx
0.0
Incr. ROIC%
5